Whilst FASD remains one of the most common causes of developmental delay, having been first recognized in 1973, many aspects remain unclear and under investigation. The rates of the disorder have been recognized to be as high as 3–8% of the population depending on the group studied. When considering poor understanding and recognition of the disorder alongside uncertain individual exposure risk prevention of the disorder remains a challenge.
The article will focus on the background, exposure risk, pathology and clinical evaluation and management of this disorder.